Why Zepp Health Corporation’s (ZEPP) Stock Is Up 6.42%
As of Friday, July 17, Zepp Health Corporation’s ZEPP share price has surged by 6.42%, which has investors questioning if this is right time to sell.Michael Rose
Stock Evaluator: Zepp Health Corporation (ZEPP)
Zepp Health Corporation ZEPP
$4.33
-0.11
-2.48%
September 15, 2026 4:00:03 PM
EST
Volume: 27,141
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NYSE | DELAYED PRICE
| SECTOR | INDUSTRY |
| Information Technology | Electronic Equipment, Instruments & Components |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Zepp Health Corporation operates as a smart wearable and health technology company worldwide. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura. The company offers smart bands, smart watches, smart rings, hearables, the Helio Strap, smart scales, and accessories; and sportswear, home appliances, and smart watch accessories. It also provides Zepp Aura, a real-time, personalized sound health solution offering health management, including emotional regulation and sports performance optimization; and provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps. The company offers its products under the Amazfit and Zepp brand names in approximately 90 countries. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is based in Gorinchem, The Netherlands.
Commentary & Analysis
Why Zepp Health Corporation’s (ZEPP) Stock Is Up 5.47%
As of Thursday, July 09, Zepp Health Corporation’s ZEPP share price has surged by 5.47%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Why Zepp Health Corporation’s (ZEPP) Stock Is Down 8.20%
As of Tuesday, July 07, Zepp Health Corporation’s ZEPP share price has dipped by 8.20%, which has investors questioning if this is right time to buy.Jenna Brashear
Why Zepp Health Corporation’s (ZEPP) Stock Is Up 5.50%
As of Monday, July 06, Zepp Health Corporation’s ZEPP share price has surged by 5.50%, which has investors questioning if this is right time to sell.Jenna Brashear
Why Zepp Health Corporation’s (ZEPP) Stock Is Up 7.61%
As of Tuesday, June 30, Zepp Health Corporation’s ZEPP share price has surged by 7.61%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Financial Summary
| Share Statistics | ZEPP | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $63.5 | $1,051.8 | 17% |
|
| Shares Out (Mil) | 15.9 | 29.1 | 26% |
|
| Institutional Ownership | 30.7% | 80.9% | 13% |
|
| Float (Mil) | 6.1 | 37.5 | 14% |
|
| Beta | 1.89 | 1.09 | 90% |
|
| Avg Daily Volume (000s) | 70 | 181 | 32% |
|
| Price Change (52-week) |
(91.4%) | 65.2% | 4% |
|
| Growth | ZEPP | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | (23.5%) | 4.8% | 2% |
|
| Net Income (5yr) | (25.8%) | 2.2% | 16% |
|
| EPS (5yr) | (26.1%) | 9.1% | 10 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (65.9%) | (14.9%) | 3% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | ZEPP | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $259 | $494 | 34% |
|
| Net Income (TTM) (Mil) | ($40) | $8 | 18% |
|
| EPS (TTM) | ($2.520) | $0.300 | 13% |
|
| Operating Cash Flow (TTM) (Mil) | na | $11 | na |
|
| Net Cash Flow (TTM) (Mil) | na | $3 | na |
|
| Long-Term Debt (Q1) (Mil) | $61 | $16 | 41% |
|
| Enterprise Value (Q1) (Mil) | $447 | $1,065 | 33% |
|
| Valuation | ZEPP | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.30 | 2.43 | 4% |
|
| P/E | na | 30.0 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.5 | na |
|
| Ratios | ZEPP | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 38.6% | 32.0% | 48% |
|
| Net Margin | (15.8%) | 2.5% | 18% |
|
| ROA | (6.7%) | 2.3% | 28% |
|
| ROE | (14.2%) | 5.1% | 26% |
|
| Liabilities to Assets | 62.0% | 41.1% | 56% |
|
| F-Score | 2 | 5 | 7% |
|
Zepp Health Corporation did not pass any screens on 9/15/2026.
